Table 2 Baseline characteristics of participants in the ADNI by their cognitive status.

From: Association of genetic risk of Alzheimer’s disease and cognitive function in two European populations

Baseline characters

Cognitively normal

Mild cognitive impairment

n

248

437

Age (years)

 Mean (SD)

75 (6)

72 (7)

 Range

60–90

55–91

Male (%)

128 (51.6)

262 (60.0)

Education (years)

 

 Mean (SD)

16.4 (2.7)

16.0 (2.9)

 Range

6–20

6–20

BMI (kg/m2)

 Mean (SD)

25.7 (4.0)

26.7 (4.9)

 Range

18.4–45.8

17.9–50.9

Ever smokers (%)

95 (38.3)

163 (37.3)

APOE4 risk allele frequency, %

15.3

27.4

APOE4 risk allele (%)

 Non carrier

178 (71.8)

236 (54.0)

 Carrier

70 (28.2)

201 (46.0)

Mini Mental State Exam, MMSE

 Mean (SD)

29.06 (1.17)

27.93 (1.66)

 Range

24–30

23–30

Alzheimer Disease Assessment Scale 11, ADAS 11

 Mean (SD)

5.81 (2.90)

9.56 (4.34)

 Range

0–19

1–26

Alzheimer Disease Assessment Scale 13, ADAS 13

 Mean (SD)

9.13 (4.25)

15.35 (6.66)

 Range

0–24

2–36

Montreal Cognitive Assessment, MoCA

 Mean (SD)

25.66 (2.26)

23.63 (2.99)

 Range

19–30

15–30

Functional Assessment Questionnaire, FAQ

 Mean (SD)

0.17 (0.67)

2.86 (3.91)

 Range

0–6

0–22

ADNI memory summary score, ADNI_MEM

 Mean (SD)

1.04 (0.56)

0.30 (0.67)

 Range

– 0.3 to 3.1

– 1.5 to 2.2

ADNI executive function score, ADNI_EF

 Mean (SD)

0.82 (0.76)

0.37 (0.85)

 Range

– 1.0 to 3.0

– 2.0 to 3.0

ADNI language summary score, ANDI_LAN

 Mean (SD)

0.89 (0.73)

0.32 (0.77)

 Range

– 1.0 to 3.1

– 2.0 to 2.6

ADNI visuospatial summary score, ADNI_VS

 Mean (SD)

0.28 (0.57)

0.05 (0.72)

 Range

– 1.6 to 0.7

– 2.5 to 0.7

  1. Body mass index, BMI.
  2. Mean (standard deviation) and Range (minimum−maximum) for continuous variables, counts (%) for categorical variables.